Cancer

News

AZ signs multi-billion cancer R&D deal with Daiichi Sankyo

AstraZeneca is to raise $3.5 billion to fund a global development and marketing collaboration with Daiichi Sankyo, for an antibody-drug conjugate and potential new targeted cancer medicine,

News

AZ gets NICE nod for ‘big advance’ Imfinzi in lung cancer

AstraZeneca has won the backing of NICE for its cancer immunotherapy Imfinzi for non-small cell lung cancer (NSCLC), with the drug made available via the Cancer Drugs Fund for now.

News

GSK mulls filings for multiple myeloma drug

GlaxoSmithKline has announced more data making the case for its multiple myeloma antibody-drug conjugate GSK2857916, confirming that almost two thirds of patients responded to the drug afte

News

Celgene gets US patent let-off ahead of BMS merger

Shares in Celgene ticked up yesterday after a let-off in a US court case challenging the patents on its multi-billion dollar cancer drug Revlimid, a decision that could ease shareholder ten

Views & Analysis

How T-cell therapy saved my life

Judy Perkins’ stage 4 cancer was eradicated after she joined a clinical trial for T-cell therapy.

News

AZ joins with Seres to research role of gut microbiome in ca...

AstraZeneca has announced an immuno-oncology collaboration with US biotech Seres Therapeutics, which will focus on increasing understanding of the gut microbiome in order to increase effica

AZ signs multi-billion cancer R&D deal with Daiichi Sankyo

AZ gets NICE nod for ‘big advance’ Imfinzi in lung cancer

GSK mulls filings for multiple myeloma drug

Celgene gets US patent let-off ahead of BMS merger

How T-cell therapy saved my life

AZ joins with Seres to research role of gut microbiome in ca...

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks